CLINICAL_TRIALS
trial_result
· 2021-09-17
Clinical Trial Update: A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease [Phase 2]
Summary
Phase 2 trial evaluating pridopidine in Huntington's disease; the study is terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prilenia | Conditions: Huntington's Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-09-17